Large-scale testing (Phase 3)Study completedNCT00046254
What this trial is testing
Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
Who this might be right for
OsteoporosisHip Fracture
Novartis Pharmaceuticals 2,127